Last checked at 
LONDON (Alliance News) - The following UK shares received analyst recommendations Thursday morning:
----------
FTSE 100
----------
TRADERS: CREDIT SUISSE RAISES TUI TRAVEL TO 'OUTPERFORM' ('NEUTRAL')
----------
UBS RAISES IMPERIAL TOBACCO PRICE TARGET TO 2,900 (2,750) PENCE - 'BUY'
----------
SOCGEN CUTS KINGFISHER PRICE TARGET TO 315 (320) PENCE - 'HOLD'
----------
DEUTSCHE BANK CUTS KINGFISHER PRICE TARGET TO 415 (430) PENCE - 'BUY'
----------
NOMURA RAISES KINGFISHER PRICE TARGET TO 335 (330) PENCE - 'NEUTRAL'
----------
NUMIS RAISES ADMIRAL GROUP TO 'BUY' ('ADD') - TARGET 1630 (1720) PENCE
----------
BERENBERG RAISES ASTRAZENECA PRICE TARGET TO 4240 (3775) PENCE - 'HOLD'
----------
BERENBERG RAISES GLAXOSMITHKLINE PRICE TARGET TO 1575 (1520) PENCE - 'HOLD'
----------
GOLDMAN CUTS ASSOCIATED BRITISH FOODS PRICE TARGET TO 2,550 (2,600)P - 'SELL'
----------
CITIGROUP RAISES BARRATT DEVELOPMENTS PRICE TARGET TO 465 (460) PENCE - 'BUY'
----------
DEUTSCHE BANK RAISES BARRATT DEVELOPMENTS TARGET TO 506 (475) PENCE - 'BUY'
----------
NOMURA RAISES WHITBREAD PRICE TARGET TO 4875 (4770) PENCE - 'BUY'
----------
CITIGROUP RAISES SMITHS GROUP PRICE TARGET TO 1,270 (1,224) PENCE - 'SELL'
----------
JEFFERIES RAISES PERSIMMON PRICE TARGET TO 1,567 (1,461) PENCE - 'HOLD'
----------
NUMIS INITIATES LONDON STOCK EXCHANGE WITH 'HOLD' - TARGET 2,074 PENCE
----------
FTSE 250
----------
TRADERS: MORGAN STANLEY RESUMES POLYMETAL WITH 'EQUAL-WEIGHT' - TARGET 535P
----------
GOLDMAN RAISES BIG YELLOW GROUP TARGET TO 665 (654)P - 'CONVICTION BUY LIST'
----------
TRADERS: PANMURE RESUMES INFORMA WITH 'BUY' - TARGET 620 PENCE
----------
GOLDMAN RAISES BIG YELLOW GROUP TARGET TO 665 (654)P - 'CONVICTION BUY LIST'
----------
HSBC CUTS WILLIAM HILL TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 365 (385) PENCE
----------
HSBC CUTS LADBROKES PRICE TARGET TO 120 (125) PENCE - 'UNDERWEIGHT'
----------
HSBC RAISES BETFAIR PRICE TARGET TO 1,280 (1,230) PENCE - 'OVERWEIGHT'
----------
EXANE BNP INITIATES SPIRAX-SARCO WITH 'UNDERPERFORM' - TARGET 2,600 PENCE
----------
CANACCORD CUTS ASHMORE GROUP TO 'SELL' ('HOLD') - TARGET 300 (360) PENCE
----------
NUMIS CUTS DIRECT LINE TO 'HOLD' ('ADD') - TARGET 305 (300) PENCE
----------
NUMIS CUTS ESURE GROUP PRICE TARGET TO 285 (320) PENCE - 'ADD'
----------
MORGAN STANLEY RAISES BWIN.PARTY TO 'EQUAL-WEIGHT' ('UNDERWEIGHT')
----------
MORGAN STANLEY CUTS BWIN.PARTY PRICE TARGET TO 100 (105) PENCE
----------
MAIN MARKET AND AIM
----------
LIBERUM INITIATES BURFORD CAPITAL WITH 'BUY' - PRICE TARGET 156P
----------
LIBERUM INITIATES JURIDICA INVESTMENTS WITH 'BUY' - TARGET 157P
----------
NUMIS RAISES M&C SAATCHI PRICE TARGET TO 380 (369)P - 'BUY'
----------
MACQUARIE RAISES PURECIRCLE PRICE TARGET TO 700 (650) PENCE - 'OUTPERFORM'
----------
MACQUARIE CUTS HANSARD GLOBAL PRICE TARGET TO 120 (130) PENCE - 'OUTPERFORM'
----------
CANACCORD RAISES ADVANCED MEDICAL SOLUTIONS PRICE TARGET TO 112 (101)P - 'HOLD'
----------
CANACCORD CUTS ALLIANCE PHARMA PRICE TARGET TO 35 (38) PENCE - 'HOLD'
----------
CANACCORD CUTS PETROPAVLOVSK PRICE TARGET TO 70 (85) PENCE - 'SPECULATIVE BUY'
----------
SHORE CAPITAL CUTS STHREE TO 'HOLD' ('BUY') - TARGET 344 PENCE
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2014 Alliance News Limited. All Rights Reserved.
22 Jan 2024 17:08
Fate of most remaining Zantac lawsuits weighed by Delaware judge
Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.
Read more